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Tamoxifen (TAM) is a drug used for treatment and prevention of breast cancer. 
However, TAM has been reported to induce liver tumors in several animal models due to 
overproduction of free radicals and lipid peroxidation. Thymoquinone (TQ), from Nigella 
sativa seeds, is a Middle East natural medicine and it has been used to treat a number of 
diseases, including cancer. The aim of my study was to investigate the effect of TQ and 
TAM on tumor development, lipid peroxidation level, and total antioxidant capacity in 
DMBA treated female Sprague-Dawley rats. Five groups of 10 rats (control, DMBA, 
TAM, TQ, and TAM+TQ) were used. Mammary tumors were induced by DMBA which 
was given by oral gavage to four groups: DMBA, DMBA+ TAM, DMBA+ TQ, and 
DMBA+ TAM & TQ. The control group received tap water only. Starting three weeks 
later, TAM and/or TQ were administered daily for 10 weeks. Mammary tumors were 
found in two DMBA treated animals. There was coloration in the mammary glands in 
four other DMBA treated animals. No mammary tumors or mammary gland coloration 
was observed in other groups. Rats treated with TAM showed a significantly higher level 
of lipid peroxidation when compared to control (P<0.05). However, the administration of 
TQ together with TAM showed significant decrease in lipid peroxidation level compared 
to treatment with TAM alone (P<0.05). Total antioxidant capacity did not differ among 
the groups (P=0.791). Average body weight gain during 12 weeks differed significantly 
among the groups (P<0.001). TAM treated rats had a lower body weight gain when 
compared with other animals and this was not ameliorated by TQ. In conclusion, both 
TAM and TQ appeared to prevent tumor induction by DMBA.TAM had two adverse 
effects on the rats: increasing in lipid peroxidation levels and reduction in body weight 
gain. TQ ameliorated the adverse effect of TAM on lipid peroxidation but not body 
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weight gain. My study is the first to show the anticancer/antitoxic effects of TQ and TAM 
together on mammary tumor and lipid peroxidation level. Data from this study suggested 
that the combination therapy of TQ and TAM could be a safer anticancer drug than TAM 
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Breast Cancer  
 Breast cancer is the most common cancer among women, with more than 210,000 
cases diagnosed in the United States alone every year (Siziopikou, 2013). Breast 
carcinoma is a disease in which abnormal cells in the mammary glands divide and 
multiply in an uncontrolled way. This disease is divided into two major types:  
Non-invasive breast cancer (in situ): is an abnormal growth of the cells still 
within the area in which it started. It is classified as ductal carcinoma in situ or 
lobular carcinoma in situ.  
• Ductal carcinoma in situ: is the most common type of non-invasive 
that presents in the duct and does not go through the duct walls into the 
surrounding tissues.  
• Lobular carcinoma in situ: is a very early form of breast cancer that 
develops within the lobules of the breast (Richie & Swanson, 2003).    
A. Invasive breast cancer: is a type of breast cancer that starts in the ducts or 
lobules and spread to nearby or distant tissue of the body. Paget’s disease is a 
rare form of invasive breast cancer and it begins in the ducts and spreads to 
the skin of the nipple and areola (Muttarak et al., 2011). 
Reactive Oxygen Species and Oxidative Stress 
Reactive oxygen species (ROS) have been implicated in the development of 
breast cancer. ROS are products of normal cellular metabolism (Karihtala & Soini, 2007). 
ROS are divided into free radicals and non-radical ROS. Free radicals, which contain one 
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Non-radical ROS include hydrogen peroxide (H2O2), hypochloride (HOCI), and organic 
hydroperoxide (ROOH) (Storz, 2005).  
Reactive oxygen species are generated in our body by various endogenous factors 
such as many enzymatic activities like proteins within the plasma membrane, lipid 
metabolism within the peroxisomes, as well as the activity of various cytosolic enzymes 
such as cyclooxygenases (Droge, 2002; Klaunig et al., 2010; Shinde et al., 2012). 
Although all these endogenous sources contribute to the ROS production, the major 
source of ROS is the mitochondria.  
Most the energy that our cells need to live depends on a mitochondrial process 
that requires oxygen (O2). In this process, which is called oxidative phosphorylation, 
most of O2 (>95%) is used by the mitochondria to produce ATP. ATP generation is 
coupled with a reaction in which O2 is reduced to H2O. Under certain conditions, some of 
oxygen (<0.1% to 5%) is not completely oxidized to water but rather to the production of 
reactive oxygen species, primarily the superoxide anion (Clark, 2002).  
On the other hand, exogenous factor may also contribute to the production of 
ROS. For example, ionizing radiation causes the formation of water radiolysis products 
that contain some reactive oxygen species (Yamamori et al., 2012). 
Reactive oxygen species normally exist in living cells in balance with 
biochemical antioxidants. This balance is essential for the health and survival of 
organisms. Oxidative stress occurs when this critical balance is disrupted because of 
excess ROS and/or depletion of antioxidant or repair enzymes (Halliwell & Gutteridge, 
2007). The results of oxidative stress may include increased cell proliferation, cell injury, 
 
senescence, and cell death (
plays an important role in the development of chronic diseases such as cancer, arthritis, 
autoimmune disorders, cardiovascular and neurodegenerative diseases (Shinde et al.
2012).    
Oxidative Stress and Cancer
 Reactive oxygen species
reaction or alteration of cellular processes 










Figure 1. Multistage process of cancer. A. initiation, B. promotion, and C. progression
(Sato, 2008).   
  Oxidative stress interacts with all three stages of this process. In the initiation 
stage, which is caused by DNA alteration, ROS may produce DNA damage by 
introducing gene mutations and structural alterations of the DNA. During the promotion 
stage, which is caused by the expression of
contribute to abnormal gene expression, blockage of cell to cell communication
modification of second messenger systems
proliferation or a decrease in apoptosis of the initiated cell population. In the pro
stage, defined as the development of a premalignant lesion into a malignant one, 
Halliwell & Gutteridge, 2007). In addition, oxidative stress 
 
 play a major role in tumor promotion by direct chemical 
(Vina et al., 2006). Cancer is a multistage 
 a latent phenotype of initiated cells, ROS can 









oxidative stress may participate by adding more DNA alterations to the initiated cell 
population (Halliwell & Gutteridge, 2007; Klauniget et al., 1998). 
Furthermore, reactive oxygen species can activate a variety of transcription 
factors like nuclear factor kappa B (NF-κB), activating protein-1 (AP-1), and β-catenin. 
The activation of these transcription factors contributes to tumor development by the 
regulation of cellular proliferation, angiogenesis, and metastasis. For example, ROS have 
been shown to have an impact on NF-κB regulation. Expression of NF-κB has been 
shown to promote cell proliferation, whereas inhibition of NF-κB activation blocks cell 
proliferation (Reuter et al., 2010). Additionally, cell lines from different cancers, 
including colon, breast, pancreas, and squamous cell carcinoma, have all been reported to 
express activated NF-κB (Bours et al., 1994). 
Oxidative Stress and Lipid Peroxidation 
 Lipid peroxidation is defined as the oxidative damage of polyunsaturated lipids in 
cell membranes, which contain two or more carbon-carbon double bonds (Evans & 
Burdon, 1993). Many toxic products result from the formation of lipid peroxidation and 
these have an impact at a site away from the area of their generation. Membrane lipids 
such as mitochondrial membrane lipids and plasma membranes are more susceptible to 
lipid peroxidation than other lipids. Therefore, the damage caused by lipid peroxidation 
affects the function of the cells and their survival (Devasagayam et al., 2003).   
 Reactive oxygen species can change the membrane lipids, which contain a high 
concentration of polyunsaturated fatty acid, and cause the lipid peroxidation (Barrera, 
2012). The formation of lipid peroxidation results in reactive aldehydes, including 
malondialdehde (MDA) and 4-hydroxy-2-noneal (4-HNE), which demonstrate high 
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reactivity with protein and DNA (Klaunig et al., 2010). Malondialdehdes also react with 
DNA bases and can introduce mutagenic lesions (Halliwell & Gutteridge, 2007).  
 Lipid peroxidation plays a major role in the pathogenesis of several diseases, 
including atherogenesis, ischemia, and cancer (Halliwell & Gutteridge, 2007). Karihtala 
et al. (2011) reported that the level of 4-hydroxy-2-nonenal, which is considered as a 
marker of lipid peroxidation, increased during breast carcinogenesis. Several studies 
suggested that lipid peroxidation products act as bioactive molecules in physiological and 
pathological conditions. These compounds may affect and modulate several cell 
functions including signal transduction, gene expression, cell proliferation, and the 
response of the target cell (Parola et al., 1999).   
Antioxidant Defense 
 An antioxidant is defined as a substance that when present at low concentrations 
compared with those of an oxidizable substrate, such as fats, proteins, carbohydrates or 
DNA, significantly delays or prevents oxidation of that substrate (Halliwell, 1990). Some 
antioxidants, such as glutathione, and uric acid, are produced endogenusly. Other 
antioxidants, like vitamins A, C and E, beta carotene, and lycopene, are acquired in food 
(Lobo et al., 2010).  
Antioxidants are divided into two groups based on mechanism of action: (1) 
chain-breaking antioxidants, such as vitamin E and beta-carotene, break the chain of free 
radical formation by donating an electron to stabilize existing free radical; and (2) 
preventive antioxidants are enzymes that scavenge initiating radicals before they start an 
oxidation chain (Scheibmeir et al., 2005). 
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Antioxidant enzymes include superoxide dismutase, glutathione reductase, 
glutathione-S-transferase, and glutathione peroxidase. Nonenzymatic antioxidants include 
ascorbic acid, glutathione, melatonin, vitamin E, and uric acid (Halliwell & Gutteridge, 
2007). The main role of superoxide dismutase is to catalyze the dismutation of 
superoxide to hydrogen peroxide, which may prevent further generation of free radicals. 
Glutathione interacts with free radicals by donating a hydrogen atom. This reaction 
provides protection by neutralizing reactive hydroxyl radicals that are thought to be a 
major source of free radical pathology, including cancer (Clark, 2002).  
Antioxidants are consumed rapidly during the scavenging of ROS, so they need to 
be regenerated or replaced by new endogenous formation or dietary - derived compounds 
(Ghiselli et al., 2000). Antioxidants are provided by a healthy diet that includes variety of 
fruits, vegetables, and herbs.  
Nigella sativa and Thymoquinone 
Nigella sativa, commonly known as black seed, is a Middle Eastern natural 
medicine. In Islam, it is regarded as one of the greatest forms of healing medicine 
available. The Prophet Muhammad, peace be upon him, once stated that the black seed 
can heal every disease except death. Nigella sativa is an annual herbaceous plant 
belonging to dicotyledon of the Ranunculaceae family. It grows in the Middle East, 
Western Asia, and Europe. It has been employed for many years as a spice and food 
preservative (Salama, 2010). The black seeds have been used in herbal medicine by 
various cultures and civilizations to treat a number of diseases and as a supplement to 
maintain good health (Butt & Sultan, 2010). Nigella sativa seed is used in folk medicine 
as an antispasmodic, antihelminthic, antiseptic, antiarthritic, nerve tonic, appetizer, 
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emmenagogue, and for the treatment of ascites, asthma and pustular dermatitis (Kanter et 
al., 2003).   
Nigella sativa contains both fixed and essential oils, proteins, alkaloids and 
saponin. The major component of the essential oil is thymoquinone (TQ). Many studies 
have indicated that TQ has antioxidant effects and has been shown to protect against 
heart, liver and kidney damage in animal studies (Ali & Blunden, 2003).  
Antioxidant /Anticancer Activities of Nigella sativa and Thymoquinone 
The anticancer effects of Nigella sativa seed and its extracts have been 
investigated by a large number of researchers using both in vivo animal models and in 
vitro cancer cell lines. Bourgou et al. (2010) investigated the antioxidant and anticancer 
activities of the essential oil from Tunisian Nigella sativa seed and its main components. 
The results of this study indicated that the essential oil significantly inhibited ROS 
production and thus exhibited the ability to protect cells from oxidative stress. In 
addition, the anticancer activity of Nigella sativa was evaluated against human lung 
carcinoma A-549 and colon adenocarcinoma DLD-1 cell lines. The oil was found to 
significantly inhibit the growth of these cancer cell lines.  
Topical application of Nigella sativa seed extract inhibited dimethylbenz [a] 
anthracene/croton oil induced skin carcinogenesis in mice, delayed the onset of papilloma 
formation and reduced the mean number of papillomas per mouse (Salomi et al., 1991). 
In addition, the oral administration of Nigella sativa seeds gave protection against 
methylnitrosourea induced oxidative stress and carcinogenesis in 80% of rats and Nigella 
sativa seeds with honey together in 100% of Sprague-Dawley rats (Mabrouk et al., 2002). 
In another study, the oral administration of Nigella sativa was shown to inhibit the 
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induction and development of 1, 2- dimethylhydrazine (DMH) -induced aberrant crypt 
foci, putative preneoplastic lesions for colon cancer, without any pathological changes in 
the liver, kidneys, and spleen (Salim & Fukushima, 2003).  
TQ has been reported to possess an anti-cancer effect against a large number of 
cancer cell lines as well as in animal models. Li et al. (2010) evaluated the anticancer 
effects of TQ through inhibition of the STAT3 signaling pathway in multiple myeloma 
(MM) cells. Excess STAT3 protein may contribute to the growth of cancers by allowing 
abnormal cells to grow and divide uncontrollably. The results of this study showed that 
TQ could suppress both constitutive and inducible STAT3 activation in MM cells. Also, 
they found that TQ inhibited the proliferation and accumulation of cells in sub-G1 phase 
and apoptosis.  
TQ was also reported to possess antitumor effect on MCF-7, MDA-MB-231 and 
BT-474 breast cancer cell lines. TQ was able to reduce the migration and invasion of 
these cells (Woo et al., 2011). Moreover, TQ showed promising anti-cancer activity 
against hepatocellular carcinoma by the inhibition of HepG2 cells in a dose-dependent 
manner (Ahmed et al., 2008). 
Additionally, TQ was shown to inhibit the development of 1, 2-dimethyl-
hydrazine (DMH)-induced oxidative stress during initiation and promotion of colon 
cancer in Wistar rats (Harzallah et al., 2012). TQ also was found to be effective in 
protecting mice against imidacloprid (IMI)-induced oxidative stress by enhancing 
antioxidant defense mechanisms (Ince et al., 2013). In another study, TQ 
supplementation prevented the development of diethylnitrosamine (DENA)-induced 
initiation of liver cancer by decreasing oxidative stress (Ahmed et al., 2010).    
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When TQ is combined with other anticancer drugs, it may enhance the 
performance of these drugs. For example, Jafri et al. (2010) evaluated the antineoplastic 
effect of TQ in combination with cisplatin, which is the most active chemotherapeutic 
agent for the treatment of non-small cell lung cancer (NSCLC) and small cell lung cancer 
(SCLC) using in vitro and in vivo techniques. The results showed that the administration 
of TQ and cisplatin together inhibited proliferation of NSCLC and SCLC cell lines. 
Additionally, the combination of TQ and cisplatin significantly reduced tumor volume 
and tumor weight in a mouse model.  
Another study by Arafa et al. (2011) examined the anti-proliferative effects of TQ 
in doxorubicin-resistant human breast cancer cells. Doxorubicin is one of the clinically 
most important anti-neoplastic agents and possesses a wide spectrum of anti-cancer 
activity against various solid tumors, including breast cancer. However, the development 
of doxorubicin resistance limits its use in treating breast cancer patients. Drug resistance 
is associated with activation of signaling pathways such as the phosphatidylinositol-3 
kinase (PI3K)/Akt or suppression of tumor suppressor genes, including PTEN. The 
results of this study showed that TQ induces apoptosis in doxorubicin-resistant breast 
cancer cells through up-regulation of PTEN at transcription level. The up-regulated 
PTEN, in turn, inhibited the PI3K/Akt pathway and induced p53 and p21 protein 
expression, thereby inducing G2/M cell cycle arrest and apoptosis.  
Thymoquinone and Lipid Peroxidation 
Lipid peroxidation is an important step in the pathogenesis of several disease 
states. It is generated in small amounts by the effect of reactive oxygen species (Mylonas 
& Kouretas, 1999). Antioxidants may delay the start or slow the rate of the lipid 
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peroxidation reaction by inhibiting the formation of free radicals (Dauqan et al., 2011). 
TQ has been reported to inhibit lipid peroxidation in several studies. Mansour et al. 
(2002) reported that the oral administration of TQ reduced the hepatic and cardiac lipid 
peroxidation in Swiss albino mice. In another study, the oral intake of Nigella sativa oil 
for four weeks prior to induction of hepatotoxicity by D-galactosamine or carbon 
tetrachloride gave complete protection against D-galactosamine (El-Dakhakhny et al., 
2000). In the same study, Nigella sativa oil showed a favorable effect on the serum lipid 
pattern by decreasing serum total cholesterol, low density lipoprotein, and triglycerides, 
and increasing high density lipoprotein level.  
Tamoxifen 
Tamoxifen (TAM) is an antiestrogen agent first synthesized in 1966 by Harper 
and Walple at the Imperial Chemical Industries in Great Britain. The compound was 
developed first as an antifertility drug but its antiestrogenic properties led to its 
evaluation in the treatment of breast cancer in 1970 (Legha, 1988). In 1977, TAM was 
approved for the prevention and treatment of breast cancer by the United States Food and 
Drug Administration (Haskell, 2003).  
TAM is used to treat women whose breast cancers express estrogen receptors 
(ER) (White, 1999). Estrogens are steroid compounds that are important to develop and 
maintain female reproductive organs. The primary source of estrogens is ovaries. The 
granulosa cells, which surround an ovum within an ovarian follicle, secrete large amount 
of estrogens during the days before ovulation, when the ovum and follicle are maturing 
(Carlberg, 2011).  
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The targets of estrogens include breast, all the other reproductive organs, brain, 
bone, and liver. The tissues affected by estrogen molecules contain estrogen receptors, 
which are protein molecules. Therefore, when estrogens circulate through the 
bloodstream, they exert effects only on cells that contain estrogen receptors. There are 
three known types of estrogen receptors: estrogen receptor alpha (ERα), estrogen receptor 
beta (ERβ), and GPER1 (Carlberg, 2011).  
Estrogen receptors normally reside in the cell’s nucleus, along with DNA 
molecules. Therefore, when an estrogen molecule enters a cell and passes into the 
nucleus, the estrogen binds to its receptor, activating it by altering its shape slightly. This 
estrogen-receptor complex then binds to specific DNA sites, called estrogen response 
elements. After it has attached to estrogen response elements in DNA, this estrogen-
receptor complex binds to coactivator proteins and nearby genes become active. The 
active genes produce molecules of messenger RNA, which guide the synthesis of specific 
proteins. These proteins can then influence cell behavior in different ways, depending on 
the cell type involved. In breast tissue, for example, estrogen triggers the proliferation of 
cells lining the milk glands in the breast, thereby preparing the breast to produce milk if 
the woman should become pregnant (Carlberg, 2011; National Cancer Institute).  
Unfortunately, estrogen in some cases may contribute to the growth of breast 
cancer by stimulating breast (cancer and normal) cell proliferation. That occurs when the 
breast cells already possess DNA mutations that increase the risk of developing cancer. 
Approximately 75% of all breast cancers are ER- positive, the type of breast cancer that 
sensitive to estrogen (National Cancer Institute). 
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A class of drug called selective estrogen receptor modulators (SERMs) can be 
used to prevent or treat diseases of estrogen-responsive tissues (Carlberg, 2011). TAM is 
the oldest and most prescribed SERM. TAM is chemically similar to estrogen, and binds 
in the same site on the estrogen receptor as the natural hormone. Therefore, TAM exerts 
its action by fitting into the estrogen receptors and blocking estrogen from acting on the 
cells (Gadducci et al., 2005). This action is responsible for the pharmacological effects of 
TAM.  
Side Effects of Tamoxifen 
TAM has been used in the therapy of advanced breast cancer since 1970. 
Prevention trails have been initiated in which TAM is given to healthy women at high 
risk of developing breast cancer. However, several studies indicated that the long-term 
exposure to TAM may be associated with some side effects. TAM has been shown to 
increase the incidence of liver tumors in several strains of rat. In humans, long-term 
treatment of TAM is associated with an increased risk of endometrial cancer (Karki et al., 
2000). 
TAM is metabolized by the human cytochrome P450s 3A4, 2C9, 2B6, 2C8, 
2C19, 2D6, 1A1, 1A2, and 2A6 and is also an effective inducer of P450s 2B2, 2B1, and 
3A in rat liver at doses comparable with the therapeutic doses used in humans (Dehal & 
Kupfer, 1997). Cytochromes P450 are hemoproteins that catalyze the metabolism of a 
diverse group of xenobiotics (drugs, environmental pollutants, pesticides, and herbicides) 
and several biologically active endogenous compounds (steroids, fatty acids) (Sridar et 
al., 2002). The major products of the metabolism of TAM are tamoxifen-N-oxide, formed 
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by flavin containing monooxygenase, and N-desmethyl and 4-hydroxytamoxifen, formed 
by cytochrome P450.    
TAM has been shown to be a hepatocarcinogen in rats due to overproduction of 
free radicals and lipid peroxidation during TAM metabolism (Ahotupa et al., 1994; 
Nazarewicz et al., 2007; Tabassum et al., 2006). The hepatotoxicity-inducing mechanism 
of TAM appears to involve mitochondrial injury, which causes steatosis because of 
impaired beta-oxidation of fatty acids, and leads to generation of ROS and ATP depletion 
(Farrel, 2002). Tabassum et al. (2006) reported that TAM induced lipid peroxidation and 
inhibited enzymes of the antioxidant defense system in Swiss albino mice. Caballero et 
al. (2001) reported that long- term treatment with TAM enhanced hepatocarcinogenesis 
induced by p- dimethylaminoazobenzene in mice. In another study, the strong 
hepatocarcinogenic effect of TAM was observed in the high-dose female rats (Williams 
et al., 1993). 
 Administration of an antioxidant, such catechin, has been effective in preventing 
the toxicity of TAM (Tabassum et al., 2007). El-Beshbishy (2005) reported that the oral 
administration of dimethyl dimethoxy biphenyl dicarboxylate, which is a traditional 
Chinese medicine, together with TAM resulted in increasing the antioxidant enzyme 
activities and decreasing lipid peroxidation in female albino rats. Parvez et al. (2008) 
investigated the effect of pre-treatment with taurine, a natural amino acid known to 
possess antioxidant activity, on the toxicity of TAM in mouse liver mitochondria. The 
results showed the pre-treatment of Swiss albino mice with taurine markedly lowered 
mitochondrial lipid peroxidation, and restored enzymatic and non-enzymatic antioxidants 




In summary, breast cancer is the most common cancer in women worldwide. 
TAM is a drug used for treatment and prevention of breast cancer. However, TAM has 
been reported to induce liver tumors in several animal models due to overproduction of 
free radicals and lipid peroxidation. On the other hand, TQ, from Nigella sativa oil, 
shows promising effects against neoplastic activity in various tumor cell lines in vitro and 
in vivo. This activity may be attributed to its inhibitory effects on cancer cell growth and 
its capability for inducing apoptosis. In addition, TQ been reported to have antioxidant 
effects and has been shown to protect against liver damage in several animal studies. TQ 
also has been reported to enhance the performance of other anticancer drugs.   
In my study, the combination of TAM and TQ may improve the performance of 
TAM and expand the use of TAM in breast cancer treatment by overcoming the side 
effects of TAM. Mammary tumors were induced in my study by 7, 12-dimethylbenz 
(a)anthracene (DMBA). Additionally, rats’ livers were removed and weighed to 
investigate the side effects of TAM.  
 Induction of Mammary Tumors in Rats 
 Mammary glands of several rat strains, mainly Sprague-Dawley and Wistar-
Furth, are susceptible to transformation induced by chemical carcinogens. The most 
widely used active chemical inducer of mammary carcinogenesis is 7, 12-dimethylbenz 
(a)anthracene (DMBA) (Barros et al., 2004). DMBA is metabolized by P450 enzymes in 
the rat liver. The oxidation of DMBA leads to the formation of reactive metabolites that 





The purpose of my study was to investigate the efficacy of a combination of 
thymoquinone and tamoxifen against 7, 12- dimethylbenz(a) anthracene (DMBA) 
induced mammary carcinogenesis in female Sprague- Dawley rats. By measuring the 
lipid peroxidation and total antioxidant capacity, as well as evaluating the number and the 
sizes of tumors, I evaluated the effect of these drugs in preventing mammary cancer. 
1. My first hypothesis was that the combination of TAM and TQ would decrease the 
lipid peroxidation level in experimental groups more than TAM alone.  
2. My second hypothesis was that the combination of TAM and TQ would increase 
the total antioxidant capacity in TAM+ TQ group more than TAM alone.  
3. Finally, I hypothesized that the combination of TQ and TAM would lead to a 











Materials and Methods 
Animals 
Fifty female Sprague-Dawley rats were used in this study. All the animals came 
from the Eastern Washington University Animal Facility. At the beginning of this study 
the animals were 12 weeks old. IACUC approval was granted through Eastern 
Washington University.  
The rats were randomly assigned to five groups of 10 rats each. Mishra et al. 
(2011) used six rats for their TAM group. The power of their experiment was 0.05 which 
is so low due to the sample size. On the other hand, Singh et al. (2011) used 18 rats for 
their TAM group. The power of their experiment was 1. I concluded that 10 rats for each 
group would be sufficient for determining the effect of the drugs on the rats.  
 The 50 animals used in this study were randomly placed into five groups of 
10.The groups were as follows: 
TAM group: received a single dose of DMBA, and after three weeks they 
received TAM daily for 10 weeks. 
TQ group: received a single dose of DMBA, and after three weeks they received 
TQ daily for 10 weeks. 
TAM+ TQ group: received a single dose of DMBA, and after three weeks they 
received TAM + TQ daily for 10 weeks.  
DMBA group: received a single dose of DMBA, and tap water daily for 10 weeks 
Control group: received tap water only, daily for 10 weeks. 
All animals were housed in the Eastern Washington University Animal Facility. 
The animals were placed on 12 hours light/dark cycle. The room temperature was 
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26±1ºC, and humidity was 25-30%. The animals were housed in pairs in standard cages 
and allowed free access to water and Teklad 8640 Standard Rodent Diet. The cages were 
cleaned every seven days and changed every four weeks. Body weight was measured on 
all animals every seven days to calculate the volume of drug doses.  
Drugs 
DMBA administration. Mammary tumors were induced by 7, 12- 
dimethylbenz(a) anthracene (DMBA) (Barros et al., 2004). A single dose of DMBA 
dissolved in corn oil was given by oral gavage to four groups: DMBA, TAM, TQ, 
TAM+TQ. Starting three weeks later, TAM and/or TQ were administered daily for 10 
weeks by oral gavage using the syringe and needles in Dr. Carlberg’s lab. In the fourth 
week, the same dose of DMBA was given again to the same groups of animals due to an 
error in needle length measurement.   
DMBA was purchased from Sigma Aldrich and dissolved in corn oil. The 
concentration of the solution was 20 mg DMBA per 1 ml corn oil (Barros et al., 2004). 
The volume given to each rat was equal to its weight in kg times 1 ml. For example, if the 
rat weight was 250 g the volume was 0.25 ml of the solution. 
For oral gavage, I extended the rat’s head back using an index finger on top of the 
head to raise the head so the esophagus was in a straight line. Next, I inserted the needle 
into the rat’s mouth. Once the gavage needle was properly placed, the rounded end of the 
needle was in the rat’s stomach, I slowly administered the dose. After administration, I 
removed the needle from esophagus (University of Delaware, 2010).   
DMBA is a carcinogenic agent, so some protection steps were performed before, 
during, and after the DMBA administration. Before the administration, I covered all the 
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surfaces with protective paper, and I wore a disposable lab coat with face shield mask. 
Also, I placed absorbent sheets in the animal cages so I could tell if they vomited. 
Moreover, DMBA administration was given under the hood that was also was covered by 
protective paper. After the administration, I removed all the protective paper from the 
surfaces, and the absorbent sheets from the cages. I put the disposal lab coat, face shield 
mask, protective paper, and absorbent sheets in the hazard bags. Also, I cleaned all the 
surfaces with soap and alcohol. Two weeks later, all the cages were washed twice in the 
cage washer to ensure a clean environment for the animals. Furthermore, all the rats were 
washed in warm water and placed under a heat lamp to make sure they dried completely.   
Tamoxifen and thymoquinone administration. TAM was purchased from 
Cayman Chemical. The drug arrived in a powder form, and I kept it at -20°C during the 
experiment. The dose of TAM was 10 mg/kg /day (Soujanya et al., 2011). The total 
volume of TAM needed for all of the 20 rats was determined. For an average animal 
weight of 250 g the total volume of TAM was 50 mg. Therefore, I prepared a solution 
containing 50 mg of TAM dissolved in 5 ml water daily. The dose for each rat was 
calculated as follows: the rat weight in mg/1000.  
TQ was purchased from Sigma Aldrich. The drug arrived in a crystal form, and I 
kept it at room temperature in the lab drawers. The dose of TQ was 20 mg/kg/day (Jafri et 
al., 2010). The total volume of TQ needed for all of the 20 rats was determined. For an 
average animal weight of 250 g the total volume of TQ was 100 mg. I prepared a solution 
containing 100 mg of TQ mixed with 10 ml of corn oil daily. The dose for each rat was 
calculated as follows: the rat weight in mg/1000.  
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The TAM + TQ group received the same volume of TAM and TQ in the same 
oral gavage at the same time. The volume for 250 g rat was 0.25 ml of TAM solution and 
0.25 of TQ solution.     
The gavage needles were flushed with alcohol between animals. At the end of 
each day, rats were observed for one hour after drug administration in case they vomited. 
Surfaces, drugs containers, and needles were washed with soap and alcohol.  
Evaluation of Mammary Tumors 
I inspected all rats for mammary tumors at 3 weeks after administering DMBA. 
The second evaluation was after five weeks of treatment and the last one was after 10 
weeks of treatment. To begin this procedure, I held the rat by grasping the whole body 
with my palm over the rat’s back, with forefinger behind the head and the thumb and 
second finger under the opposite axilla. I turned the rat and palpated to detect any 
mammary tumors (Assis et al., 2010). 
Blood Collection 
After 10 weeks I collected blood samples (up to 3 ml) from each rat by cardiac 
puncture (Beeton et al., 2007). Before this process some preparation steps were 
performed. I added 5 ml of distilled water to a heparin bottle. Needles 21G X 1.5 inch 
with 3cc syringes were coated with heparin to prevent blood clot formation. I put paper 
towels in the two chambers that I used for anesthesia and euthanasia. I added to the 
anesthesia chamber 6 ml of isoflurane, and 15 ml of isoflurane to the euthanasia chamber. 
Centrifuge tubes were labeled with rat identification numbers. 
Each rat was anesthetized with isoflurane in the first chamber. When the rat was 
unconscious, I removed it from the chamber and placed it on its back, with its nose in a 
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nose cone filled with isoflurane-soaked cotton. Then I inserted a 21G X 1.5 inch heparin-
coated needle connected to a 3 cc syringe below and slightly to the left of the xiphoid 
cartilage at the base of the sternum, at a 20° to 30° angle. I advanced the needle slowly, 
applying very slight negative pressure on the barrel of the syringe. Blood flowed into the 
needle when the tip entered a chamber of the heart. When collection was completed, the 
rat was euthanized with a higher dose of isoflurane in the second chamber.  
Blood samples were centrifuged at 600 ´ g, at 4°C for 10 minutes. I removed the 
plasma and aliquoted it into three microtubes per rat, one for the lipid peroxidation assay, 
one for the total antioxidant capacity assay, and a third one for Abrar Sindi’s study. For 
the lipid peroxidation assay, I added 5 µL of antioxidant Butylated hydroxytoluene 
(BHT) to each plasma sample to prevent further oxidation of lipid. Samples were labeled 
and stored at -80°C until analysis.  
Tumor Evaluation 
After euthanasia rats were dissected and evaluated for tumors. Mammary tumors 
were removed using a dissection tray, a scalpel, and a scissors. Then, I used a caliper to 
measure the width, length, and height of the tumor. Tumor volume was calculated using 
the formula: Volume =1/6πabc, where 'a'= width, 'b' = length and 'c' = height (Assis et al., 
2010). Also, photos were taken of the mammary tumors, as well as the coloration in 
mammary glands. Moreover, whole livers from rats were removed and weighted.      
Lipid Peroxidation Assay 
Evidence of lipid peroxidation in plasma was measured by the OxiSelect TBARS 
assay kit (Cell Biolabs, Inc., San Diego, California). According to the product manual the 
thiobarbituric acid reactive substances (TBARS) assay kit is a tool for the direct 
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quantitative measurement of malondialdehyde (MDA) in biological samples. MDA is a 
secondary product of lipid peroxidation that is widely used as an indicator of lipid 
peroxidation. The TBARS assay measured MDA in plasma samples using thiobarbituric 
acid (TBA), which forms an adduct with MDA when incubated at 95 °C. The MDA-TBA 
complex forms a pink color that can be read spectrophotometrically. The MDA level in 
plasma samples was quantified by comparison to an MDA standard curve.    
Preparation of standard curve. I prepared a dilution series of MDA standards in 
the concentration range of 125 µM – 0 µM by diluting the MDA Standard in deionized 
water according to Table 1 below.   
Standard tubes MDA Standard (µL) Water (µL) MDA Standard(µM) 
1 125 µL 875 µL 125 
2 250 µL of tube # 1 250 µL 62.5 
3 250 µL of tube # 2 250 µL 31.25 
4 250 µL of tube # 3 250 µL 15.63 
5 250 µL of tube # 4 250 µL 7.81 
6 250 µL of tube # 5 250 µL 3.91 
7 250 µL of tube # 6 250 µL 1.95 
8 250 µL of tube # 7 250 µL 0.98 
9 0 µL 250 µL 0.0 
  






Preparation of reagents.  
 TBA acid diluent:  2X TBA diluent was diluted (1:2) with deionized water.  
 TBA regent: I prepared a 5.2 mg/mL solution of TBA regent by weighing out 
260 mg of thiobarbituric acid (TBA). 2X TBA diluent was added and mixed vigorously 
until the powder was dissolved. I adjusted the pH of the solution to pH 3.5 with sodium 
hydroxide solution.   
Assay protocol. Each MDA-containing sample and standard was assayed in 
duplicate.  
1- 100 µL of MDA standard and plasma was added to separate centrifuge 
tubes. 
2- 100 µL of the SDS lysis solution was added to each tube and incubated 
for 5 minutes at room temperature.   
3- 250 µL of TBA regent was added to each plasma and MDA standard. 
4- Each tube was closed and incubated at 95°C in a water bath for 60 
minutes. 
5- All the tubes were placed in an ice bath for 5 minutes, and then 
centrifuged at 3000 rpm for 15 minutes. 
6- The supernatant was removed from the plasma and MDA standard. 
7- 300 µL of the supernatant was added to the new tube. 
8-  300 µL of n-Butnol was added to each plasma and standard to prevent 
the interference of hemoglobin and its derivatives.   
9-  All sample tubes were placed in a vortex mixer for 2 minutes. 
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10- After that the tubes were centrifuged at 10,000´g in the cold room for 5 
minutes. 
11- 200 µL each plasma and MDA standard was transferred to 96-well flat-
bottomed microplate.  
12- The absorbance was read at 532 nm using the spectrophotometer. The 
reaction between MDA and thiobarbituric acid (TBA) yielded a pink 
color, which peaks at 532nm. 
Total Antioxidant Capacity Assay 
The total antioxidant capacity (TAC) of plasma was measured by the OxiSelect Total 
Antioxidant Capacity (TAC) assay kit (Cell Biolabs, Inc., San Diego, California). 
According to the product manual the TAC assay is based on measurement of the 
reduction of copper (II) to copper (I) by viable antioxidants in a sample within a 96-well 
microtiter plate. Upon reduction, the copper (I) ion will react with a coupling 
chromogenic reagent that produces a color with a maximum absorbance at 490 and is 
read in a spectrophotometer. The absorbance values are then compared to a standard 
curve of uric acid antioxidant activity.  
Preparation of uric acid standard curve. A uric acid standard stock solution 
was prepared by weighing out uric acid powder for a 10 mg/mL or 60 mM solution in 1N 
NaOH. The stock solution was used to prepare serial dilutions of uric acid in deionized 
water, with the highest concentration at 1 mM diluted to 9 different concentrations with 










Resulting Uric Acid  
Concentration (mM) 
1 500 500 1 
2 500 of tube # 1 500 0.5 
3 500 of tube # 2 500 0.25 
4 500 of tube # 3 500 0.125 
5 500 of tube # 4 500 0.0625 
6 500 of tube # 5 500 0.03125 
7 500 of tube # 6 500 0.0156 
8 500 of tube # 7 500 0.0078 
9 500 of tube # 8 500 0.0039 
10 0 500 0.0 
 
Table 2: Preparation of uric acid standards.  
Preparation of reagents. 
1X reaction buffer: reaction buffer was diluted (1:100) with phosphate buffered saline.  
1X copper ion regent: copper ion reagent was diluted (1:100) with deionized water.   
1X stop solution: stop solution was diluted (1:10) with deionized water.   
Assay protocol. Each uric acid or plasma sample was tested in triplicate.  
1- 20 µL of each uric acid standard or plasma was added to the 96-well plate.  
2- 180 µL of the reaction buffer was added to each sample and standard and 
mixed with a vortexer.  
3- An initial, baseline absorbance was read at 490 nm wavelength.  
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4- The reaction started when 50 µL of the copper ion reagent was added into 
each well, and then incubated for 5 minutes on an orbital shaker. 
5- The reaction was terminated with the addition of 50 µL of the stop 
solution. 
6- The plate was read at 490 nm wavelength. 
7-  The baseline readings were subtracted from these values to produce the 
net absorbance values.  
8- Antioxidant capacities of the samples were calculated first into “mM uric 
acid equivalents” by comparison against the uric acid standard 
concentration curve.  
9- This value was then be used to obtain the “copper reducing equivalents” 
by multiplying the uric acid equivalent concentrations by 2189 (µM 
Cu2+/mM uric acid).  
10- This final value was proportional to the sample’s total antioxidant capacity 
and was used for data analysis.  
Statistical Analysis 
The number of rats with tumors and the number of rats with mammary gland 
coloration were counted. No statistical analysis was performed. 
Data for body weight gain between weeks one and 13, and liver weight were 
determined to be normally distributed by using Shapiro-Wilk test. Therefore, the one-way 
ANOVA test was used to analyze body weight gain and liver weight data.  
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For total antioxidant capacity, a mean of triplicate measurements was calculated for 
each animal. Data for total antioxidant capacity were not normally distributed. Therefore, 
the Kruskal-Wallis test was used to analyze total antioxidant capacity data.   
For lipid peroxidation levels, a mean of duplicate measurements was calculated for 
each rat. Data for lipid peroxidation were not normally distributed. Therefore, the 
Kruskal-Wallis test was used.  
Lipid peroxidation, total antioxidant capacity, body weight gain, and liver weight 






Three rats from TQ group died, probably due to an error in TQ administration. TQ 
was mixed with corn oil and that caused the needle to become slippery. The gavage 
needle may have been inserted by mistake into the trachea instead of the esophagus. All 
three rats had difficulty breathing after TQ administration and died the next day.      
During the three times of mammary tumor inspection, I was unable to feel any 
lumps that felt like tumors. After the dissection, there were mammary tumors in two 
DMBA treated rats. No tumors were found in the other groups (Figure 2, Table 3). The 




.  Additionally, there was coloration in 
mammary glands in four other DMBA treated animals and no coloration was observed in 
the other groups. Red to dark green color was noticed in mammary glands of four DMBA 
treated animals (Figure 3).  
For lipid peroxidation, the Kruskal-Wallis test showed that lipid peroxidation 
levels differed significantly among groups (P=0.017, Figure 4). Dunn’s Multiple 
Comparison test showed that the lipid peroxidation level was significantly higher in the 
TAM group when compared with control group (P<0.05). Animals receiving TQ + TAM 
treatment showed significantly lower lipid peroxidation levels than the TAM-treated 
group (P<0.05). 
For total antioxidant capacity, the Kruskal-Wallis test showed there was no 
significant difference among the groups (P=0.791, Figure 5) 
For liver weight, the one way ANOVA showed there was no significant 
difference among the groups (P=0.163, Figure 6). In addition, liver looked normal and 
there was no visible sign of liver tumor.  
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Average body weight gain differed significantly among the groups (P<0.001, 
Figure 7). Pairwise Multiple Comparison procedures showed that treatment of animals 
with TAM resulted in a significantly lower body weight gain when compared with 
control (P<0.001), DMBA (P<0.001) and TQ (P=0.012) groups. Animals receiving TQ 
+TAM treatment showed a significantly lower body weight gain when compared with 


















   Control DMBA TAM TQ TAM+TQ 
Tumor 0 2 0 0 0 
Coloration 0 4 0 0 0 
Total 0/10 6/10 0/10 0/7 0/10 
 
Table3.  Table shows the number of rats with mammary tumors or mammary gland 
coloration in control, DMBA, TAM, TQ, TAM+TQ groups.         
 
 














              
 
 
































Figure 4.  Lipid peroxidation levels in control, DMBA, TAM, TQ, TAM+TQ groups. 
The Kruskal-Wallis test showed that there was a significant difference among the groups 
(P=0.017). Lipid peroxidation level was significantly higher in the TAM group when 
compared to control and TAM +TQ groups (P<0.05). Treatment groups that do not share 
letters (a or b) are significantly different.  
  
 

















































Figure 5. Total antioxidant capacity in control, DMBA, TAM, TQ, TQ+TAM groups. 













Figure 6. Values are mean and ± S.D. for liver weight in scaled to body weight in 
control, DMBA, TAM, TQ, TQ+TAM groups. One-way ANOVA showed there was no 















































































Figure 7. Values are mean and ± S.D. for body weight gain during 12 weeks. One-way 
ANOVA showed a significant difference among the groups (P<0.001). Treatment of 
animals with TAM resulted in a significantly lower body weight gain when compared 
with control (P<0.001), DMBA (P<0.001) and TQ (P=0.012) groups. Animals receiving 
TQ +TAM treatment showed a significantly lower body weight gain when compared with 
control (P<0.001), DMBA (P<0.001) and TQ (P=0.002) groups. Treatment groups that 






In my study, I used DMBA as a carcinogen to induce mammary tumors in female 
Sprague-Dawley rats. The mechanism by which DMBA causes cancer is based on the 
metabolism of DMBA. Soujanya et al. (2011) reported that DMBA is metabolized in the 
microsomes of both liver and mammary gland. The toxic manifestation of DMBA is 
associated with its oxidative metabolism leading to the formation of reactive metabolites 
capable of generating free radicals, which play a major role in the etiology of cancer.  
The results of my study showed that there were mammary tumors in two DMBA 
treated animals. Additionally, there were four other DMBA treated rats with mammary 
gland coloration. Perumal et al. (2005) identified tumor cells in their study by the 
appearance of a red mass under the epithelial layer of mammary pad. Therefore, 60% of 
my DMBA treated rats developed mammary cancer. However, there were no mammary 
tumors or mammary gland coloration in control, TAM, TQ, TAM+TQ groups, potentially 
due to the protective role of both TAM and TQ. 
TAM is widely used in the prevention and treatment of breast cancer. TAM works 
against breast cancer by interfering with the activity of estrogen. Estrogen stimulates the 
growth of breast cancer cells. TAM binds to estrogen receptors and blocks estrogen from 
acting on the cells. In animal models, TAM was shown to be effective in preventing the 
occurrence of mammary tumors (Soujanya et al., 2011). Perumal et al. (2005) reported 
that the administration of TAM with riboflavin, niacin and coenzyme Q10, which are 
known to have antioxidant activity, resulted in decreasing mammary tumors in female 
Sprague-Dawley rats.  
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On the other hand, many studies have indicated that TQ has an anti-cancer effect 
against different carcinogenic agents or cancer cell lines. Woo et al. (2011) reported that 
TQ possesses an anti-tumor effect on MCF-7, MDA-MB-231 and BT-474 breast cancer 
cell lines. TQ was able to reduce the migration and invasion of these cells. Ahmed et al. 
(2010) reported that TQ supplementation prevented the development of 
diethylnitrosamine (DENA)-induced initiation of liver cancer by decreasing oxidative 
stress. 
Additionally, the combination of TQ with other anticancer drugs was shown to 
improve the performance of these drugs. Jafri et al. (2010) evaluated the antineoplastic 
effect of TQ in combination with cisplatin, which is the most active chemotherapeutic 
agent for the treatment of non-small cell lung cancer (NSCLC) and small cell lung cancer 
(SCLC) using in vitro and in vivo techniques. The results showed that the administration 
of TQ and cisplatin together inhibited proliferation of NSCLC and SCLC cell lines. Also, 
the combination of TQ and cisplatin significantly reduced tumor volume and tumor 
weight in a mouse model.  
The results of my study indicated that both TQ and TAM alone and together have 
a protective role against DMBA-induced mammary tumors in female Sprague-Dawley 
rats. Additionally, the results of this study show for the first time that the combination 
therapy of TQ and TAM prevented the development of mammary cancer. Therefore, my 
data provide evidence to implicate TQ alone or in combination with TAM in breast 





Lipid Peroxidation Levels 
Lipid peroxidation is generated by the effect of ROS and it is a common feature 
of several diseases, including cancer. Lipid peroxidation levels were assessed using 
TBARS assay kit. This assay depends on the measurement of MDA in plasma samples. 
MDA is a result of lipid peroxidation. It has been reported that MDA may cause DNA 
damage (Halliwell & Gutteridge, 2007).  
The results of my study showed that the lipid peroxidation level was significantly 
higher in the TAM group compared with the control group. In addition, animals receiving 
TQ + TAM treatment showed significantly lower lipid peroxidation levels than the TAM-
treated group.  
 Many studies have shown that TAM could be a hepatocarcinogen due to 
overproduction of free radicals and lipid peroxidation during hepatic TAM metabolism. 
Tabassum et al. (2006) reported that TAM induced lipid peroxidation and inhibited 
enzymes of the antioxidant defense system in Swiss albino mice. Caballero et al. (2001) 
reported that long- term treatment with TAM enhanced hepatocarcinogenesis induced by 
p- dimethylaminoazobenzene in mice. However, administration of an antioxidant, such 
catechin, has been effective in preventing the toxicity of TAM (Tabassum et al., 2007). 
El-Beshbishy (2005) reported that the oral administration of dimethyl dimethoxy 
biphenyl dicarboxylate, which is a traditional Chinese medicine, together with TAM 
resulted in lower lipid peroxidation in female rats.  
In contrast, TQ has been reported to decrease lipid peroxidation levels in several 
studies. TQ and other antioxidants delay the start of the lipid peroxidation reaction by 
inhibiting the formation of ROS. Mansour et al. (2002) reported that the oral 
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administration of TQ reduced hepatic and cardiac lipid peroxidation in Swiss albino 
mice. In another study, the oral intake of Nigella sativa oil for four weeks prior to 
induction of hepatotoxicity by D-galactosamine gave complete protection against D-
galactosamine (El-Dakhakhny et al., 2000). In the same study, Nigella sativa oil showed 
a favorable effect on the serum lipid pattern by decreasing serum total cholesterol, low 
density lipoprotein, and triglycerides, and increasing high density lipoprotein level.  
In my study, TAM did not affect liver weight which suggested that there was no 
liver tumor. However, TAM treated animals showed a significantly higher level of lipid 
peroxidation when compared to control. The administration of TQ together with TAM 
showed significant decrease in lipid peroxidation level compared to treatment with TAM 
alone. Data from this study show for the first time that the combination therapy of TQ 
and TAM may help to overcome this side effect of TAM. TQ is a natural medicine and 
many studies have indicated that there were no side effects observed with TQ 
administration. Therefore, the combination therapy could be a powerful and safe drug in 
prevention and treatment of breast cancer.   
Total Antioxidant Capacity 
Total antioxidant capacity was assessed using the OxiSelect Total Antioxidant 
Capacity assay kit. Antioxidant defense helps to protect the body from free radicals and 
their effects. The result of my study showed that total antioxidant capacity did not differ 
among the groups. There could be two reasons that total antioxidant capacity did not 
differ among groups. The dosage of TQ used, 20 mg/kg, may not have been sufficient to 
increase antioxidant level. Alternatively, the assay kit may not have measured the total 
antioxidant capacity accurately in plasma samples.   
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Several studies have indicated that TQ possesses antioxidant activity and that 
plays a major role in inhibiting the development of tumors. Harzallah et al. (2012) 
reported that TQ was shown to inhibit the development of 1, 2-dimethyl-hydrazine 
(DMH)-induced oxidative stress during initiation and promotion of colon cancer in 
Wistar rats. In the same study, TQ treated rats showed a significantly higher level of the 
antioxidant enzymes catalase, superoxide dismutase, and glutathione peroxidase levels 
when compared to control rats. Ince et al. (2013) reported that TQ was effective in 
protecting mice against imidacloprid (IMI)-induced oxidative stress by enhancing 
superoxide dismutase, catalase, and glutathione peroxidase levels.  
In contrast, long-term administration of TAM is accompanied by toxicity and 
poor antioxidant defenses. However, El-Beshbishy (2005) reported that the toxicity of 
TAM was abolished when combined with dimethyl dimethoxy biphenyl dicarboxylate, 
which is a traditional Chinese medicine. The oral administration of combination therapy 
resulted in increasing SOD, CAT and GPX levels in female rats.  
In my study, TQ did not improve the antioxidant activity of TAM+TQ group. In 
future studies an alteration in TQ doses will be useful to determine the effect of TQ in 
improving the antioxidant activities. Choosing a different assay kit might lead to different 
results.  
Body Weight Gain 
Total body weight gain over 12 weeks differed significantly among groups of 
animals. Treatment of animals with TAM in both TAM and TAM+TQ groups resulted in 
a significantly lower body weight gain when compared with other groups. TQ by itself 
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did not reduce body weight gain, but also did not affect TAM-induced reduction in 
weight gain.  
 Wade & Heller (1993) reported that the daily administration of TAM prevented 
body weight gain in rats and this was associated with a significant reduction in daily food 
intake. In addition, the reduction of body weight gain may be related to other effects of 
TAM on body composition, adipose tissue, and energy expenditure reported in rats. 
However, the effect of TAM on body weight in women is controversial. Data from two 
clinical trials indicated that at least obese women treated with TAM had lower body mass 
index than those not receiving the drug (Manni, et al., 2010). The results of my study 
showed that TAM reduced weight gain and this effect was not ameliorated by TQ.  
Conclusion 
 The purpose of my study was to investigate the effects of TQ and TAM on tumor 
development, lipid peroxidation level, and total antioxidant capacity in DMBA treated 
female Sprague-Dawley rats. My study showed that both TQ and TAM successfully 
prevented the development of mammary tumors. Moreover, the oral administration of 
TAM for 10 weeks increased the level of lipid peroxidation. Administration of TQ along 
with TAM ameliorated this effect of TAM. Therefore, the combination therapy of TQ 
and TAM could be a safer anti-cancer drug than TAM alone. In addition, the daily 
administration of TAM resulted in reduction in weight gain. TQ, however, did not affect 
body weight gain by itself, and did not prevent the reduction in weight gain caused by 
TAM. Total antioxidant capacity did not differ among the groups.  
My study shows for the first time that the combination of TQ and TAM 
successfully prevents mammary tumor development and reduces lipid peroxidation 
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induced by TAM. My data suggest that TQ alone or in combination with TAM have 
potential utility in breast cancer prevention and treatment. Clinical studies are required to 
evaluate the efficacy of adding TQ to TAM for treatment of breast cancer in women.        
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